Evidence map›Paper›PMID 33494248›Full record

ArticleInternational journal of molecular sciences2021

Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2.

Sabina Podlewska, Ryszard Bugno, Enza Lacivita, Marcello Leopoldo, Andrzej J Bojarski, Jadwiga Handzlik

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. The Different Facets of Triclocarban: A Review.Molecules (Basel, Switzerland) · 2021
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sabina PodlewskaDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland.ORCID 0000-0002-2891-5603
Ryszard BugnoMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.ORCID 0000-0003-3741-674X
Enza LacivitaDepartment of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", via E. Orabona 4, 70125 Bari, Italy.ORCID 0000-0003-2443-1174
Marcello LeopoldoDepartment of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", via E. Orabona 4, 70125 Bari, Italy.
Andrzej J BojarskiMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.ORCID 0000-0003-1417-6333
Jadwiga HandzlikDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland.ORCID 0000-0002-3674-3581
Jagiellonian University · PLMaj Institute of Pharmacology · PLUniversity of Bari Aldo Moro · IT

Funding

Narodowe Centrum Nauki SONATINA 2018/28/C/NZ7/00145
6 · The paper itself

Abstract

Serotonin receptors are extensively examined by academic and industrial researchers, due to their vital roles, which they play in the organism and constituting therefore important drug targets. Up to very recently, it was assumed that the basic nitrogen in compound structure is a necessary component to make it active within this receptor system. Such nitrogen interacts in its protonated form with the aspartic acid from the third transmembrane helix (D3x32) forming a hydrogen bond tightly fitting the ligand in the protein binding site. However, there are several recent studies that report strong serotonin receptor affinity also for compounds without a basic moiety in their structures. In the study, we carried out a comprehensive in silico analysis of the low-basicity phenomenon of the selected serotonin receptor ligands. We focused on the crystallized representatives of the proteins of 5-HT

Indexed as

AnimalsBinding SitesDatabases, PharmaceuticalDrug DiscoveryHumansLigandsModels, MolecularMolecular Docking SimulationMolecular StructureReceptors, Serotonin, 5-HT2Serotonin 5-HT2 Receptor AgonistsSerotonin 5-HT2 Receptor AntagonistsStructure-Activity RelationshipLigandsReceptors, Serotonin, 5-HT2Serotonin 5-HT2 Receptor AgonistsSerotonin 5-HT2 Receptor AntagonistsdockingG protein-coupled receptorsnonbasic ligandsserotonin receptorsstructure-based drug design

Identifiers

PMID33494248
PMCPMC7864501
OpenAlexW3121785837

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.